MAXIMIZING THE POTENTIAL OF SOUTH AFRICA: EMERGING MARKETS CASE STUDY A large multi-national drug company was conducting a global Phase III cardiovascular study. The study included 20 sites in South Africa with a target enrollment of more than 410 patients. Understanding the Challenge ? W orking w ith sit es t o address start-up issues and study-sp ecific challenges ? Competing cardiovascular studies in South Africa increased the pres

Join for free to read